Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Electrospun Silk Fibroin-CNT Fibers for Fibroblast Activatio

    2026-05-29

    Electrospun Silk Fibroin-CNT Composite Fibers: A Novel Scaffold for Fibroblast Stimulation

    Study Background and Research Question

    Tissue engineering increasingly relies on biomimetic scaffolds to support cellular repair, especially for disorders involving connective tissue integrity. Silk fibroin (SF), a protein derived from Bombyx mori cocoons, is well-regarded for its biocompatibility, controlled biodegradation, and mechanical robustness, making it a preferred matrix in regenerative medicine. However, many conditions, such as pelvic organ prolapse (POP), present a challenge because fibroblasts from affected patients exhibit impaired collagen production and tissue remodeling capacity. Recent advances in electrospinning technology have enabled the creation of fibrous matrices that closely mimic the architecture of the native extracellular matrix (ECM), but further enhancement of scaffold function—particularly electrical conductivity and mechanical strength—remains a key research goal.

    In this context, the reference study (Rathnayake et al., 2023) addressed whether incorporating functionalized carbon nanotubes (CNTs) into electrospun silk fibroin fibers could create a scaffold capable of both supporting and electrically stimulating fibroblasts from POP patients. This approach aims to directly remedy the dysfunctional phenotype of patient-derived fibroblasts, potentially advancing cell-based therapies for collagen-related disorders.

    Key Innovation from the Reference Study

    The core innovation presented by Rathnayake et al. is the fabrication of aligned, free-standing SF-CNT composite fibers via electrospinning, optimized for both biocompatibility and electrical performance. By integrating trace amounts of CNT (as low as 0.1% by weight), the researchers achieved a dramatic increase in electrical conductivity—13.7-fold with 0.1% CNT and 21.8-fold with 0.2% CNT—without compromising the inherent biocompatibility and biodegradability of silk fibroin. The alignment of the fibers further mimics the local orientation of ECM proteins, a feature critical for guiding cell growth and function.

    Importantly, the study demonstrated that these SF-CNT matrices not only provided a stable and bioactive substrate but also enabled the application of electrical stimulation to cultured fibroblasts. This dual functionality is particularly significant for attempts to reprogram or activate dysfunctional cells from patients with connective tissue disorders.

    Methods and Experimental Design Insights

    The researchers employed a systematic approach, beginning with the regeneration of silk fibroin from Bombyx mori cocoons, followed by dispersion of functionalized CNTs and electrospinning under controlled conditions. The resulting fibers were post-treated with ethanol vapor, a step that induced β-sheet formation and dramatically improved the aqueous stability of the fibers—from rapid dissolution within two minutes (as-spun) to stable persistence (>14 days) in water. This stabilization is essential for any in vitro or in vivo biomedical application.

    Characterization was performed using scanning electron microscopy (SEM) to confirm fiber morphology and alignment, while electrical conductivity was quantified using a four-point probe method. Mechanical properties were assessed via tensile testing. To evaluate biocompatibility and functional efficacy, fibroblasts isolated from POP patient tissues were seeded onto the aligned SF-CNT matrices. Electrical stimulation protocols were applied, and the cellular response was monitored by measuring the expression levels of key ECM proteins—specifically collagen I (COLI) and collagen III (COLIII)—via gene expression analysis.

    Protocol Parameters

    • Silk fibroin regeneration: Extracted from Bombyx mori cocoons using established degumming and dialysis protocols.
    • CNT incorporation: Oxidized CNTs added at 0.1% and 0.2% (w/w) to silk fibroin solution for optimal conductivity and alignment.
    • Electrospinning: Voltage and flow rate adjusted to produce well-aligned fibers with diameters mimicking native ECM fibrils.
    • Ethanol vapor posttreatment: Applied for 14 hours to induce β-sheet formation and stabilize fibers in aqueous conditions.
    • Electrical stimulation: Applied to fibroblast-seeded matrices to assess functional activation and collagen gene expression.

    Core Findings and Why They Matter

    The study's findings are notable in several respects:

    • Mechanical and electrical enhancement: Incorporating minimal amounts of CNT into silk fibroin fibers resulted in substantial improvements in both mechanical strength and conductivity. This is crucial for scaffolds intended to deliver electrical cues to cells.
    • Biocompatibility and biodegradability: Despite the addition of CNTs, the composite fibers retained characteristics essential for biomedical use, including support for cell adhesion and proliferation, as well as environmentally responsive degradation.
    • Stimulation of dysfunctional fibroblasts: Electrical stimulation via the SF-CNT scaffolds led to a remarkable upregulation of collagen gene expression in POP-derived fibroblasts. Specifically, COLIII and COLI production increased by 74-fold and 58-fold, respectively, with a favorable shift in the COLI/COLIII ratio—an outcome associated with improved tissue repair (Rathnayake et al., 2023).
    • Matrix stability: Ethanol vapor treatment ensured scaffold integrity during extended culture periods, a practical necessity for both research and translational applications.

    These results suggest that SF-CNT composite fibers are a promising platform for patient-specific cell therapies targeting collagen disorders, potentially enabling restoration of connective tissue function in conditions like POP.

    Comparison with Existing Internal Articles

    While the core innovations in the reference study focus on material fabrication and cellular stimulation, related advances in molecular biology tools are essential for analyzing gene expression changes in such workflows. For example, the internal article on the HyperScript™ First-Strand cDNA Synthesis Kit discusses how this kit supports high-fidelity cDNA synthesis from total RNA, even when templates possess complex secondary structures—an important consideration when quantifying gene expression changes in electrically stimulated fibroblasts.

    Additionally, workflow-focused resources such as Scenario-Driven Solutions: HyperScript™ First-Strand cDNA Synthesis Kit offer practical insights into boosting reproducibility and sensitivity in qPCR analyses, which are directly relevant for studies requiring robust detection of low copy gene transcripts following fibroblast stimulation.

    While these internal resources do not address scaffold fabrication directly, they provide complementary protocols for downstream molecular analysis, ensuring that the biological impacts of advanced biomaterial scaffolds can be precisely quantified.

    Limitations and Transferability

    Despite the promising results, several limitations should be acknowledged:

    • In vitro focus: The reported findings are based on in vitro cultures of patient-derived fibroblasts. The behavior of these cells in vivo, within the complex tissue environment, remains to be validated.
    • Scalability of fabrication: While electrospinning is efficient, scaling up for clinical-grade scaffold production may require additional optimization for reproducibility and sterility.
    • Patient heterogeneity: Variations in fibroblast response among different POP patients could influence therapeutic outcomes and require further study.

    Nonetheless, the methodology is broadly transferable to other scenarios in regenerative medicine where controlled cell stimulation and ECM remodeling are desired, provided that scaffold biocompatibility and functional integration are carefully validated.

    Research Support Resources

    To support workflows involving gene expression analysis of cells cultured on advanced biomaterial scaffolds, researchers can utilize the HyperScript™ First-Strand cDNA Synthesis Kit (SKU K1072). This kit features the engineered HyperScript™ Reverse Transcriptase, designed for high-efficiency cDNA synthesis from challenging RNA templates, including those with complex secondary structures or low abundance. Its compatibility with PCR amplification and qPCR reaction protocols ensures reliable quantification of cellular responses, such as collagen gene upregulation observed in the referenced study. For additional workflow recommendations and troubleshooting, internal resources such as the HyperScript First-Strand cDNA Synthesis Kit: Optimizing cDNA Synthesis article provide further detailed guidance.